This article is more than 5 years old. Information may no longer be current.

Telemedicine screening initiative for ROP shows promise

Ophthalmic Surg Lasers Imaging. 2011;42(1):12-19.

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

A telemedicine screening initiative for retinopathy of prematurity was found to be reliable for identifying treatment-warranted disease, a study said.

The SUNDROP (Stanford University network for diagnosis of retinopathy of prematurity) screening initiative was designed to identify infants with ROP through digital images analyzed at a remote location.

The retrospective analysis evaluated 460 eyes of 230 infants screened with the RetCam II (Clarity Medical Systems) over a 36-month period.

According to the study, the SUNDROP initiative identified every case of treatment-warranted ROP and had a sensitivity of 100% and a specificity of 99.5%.

Researchers observed 10 infants with ROP that warranted a referral, of whom nine received laser photocoagulation. Although one infant regressed spontaneously, no adverse outcomes or retinal detachments were reported.

"It is important to note that SUNDROP was designed to employ telemedicine not as replacement of bedside examinations, but rather as their supplement," the authors said.